Article
The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers.
Urologic oncology - 1 May 2015
Cremers Ruben G, Eeles Rosalind A, Bancroft Elizabeth K, Ringelberg-Borsboom Janneke, Vasen Hans F, Van Asperen Christi J, Schalken Jack A, Verhaegh Gerald W, Kiemeney Lambertus A
Abstract excerpt
OBJECTIVE: To evaluate the additive value of the prostate cancer gene 3 (PCA3) urine test to serum prostate-specific antigen (PSA) in prostate cancer (PC) screening among breast cancer, early-onset gene (BRCA) mutation carriers. This study was performed among the Dutch participants of IMPACT, a large international study on the effectiveness of PSA screening among BRCA mutation carriers. MATERIALS AND METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.